These results indicate a potential risk in the use of semaglutide in patients with NENs expressing GLP-1 receptors
In addition, similar to other GLP-1 RAs, it affects different stages of the pathophysiological process of CVDs, from risk factors like dyslipidemia, hypertension, obesity, diabetes, and coronary artery atherosclerosis to more advanced stages such as myocardial ischemia, atherothrombosis, myocardial infarction, left ventricular remodeling, and death, without raising the risk of arrhythmia, hospitalization, or exacerbating heart failure [35, 41]
Neuroscience 376 , 4871 (2018)
The score rises as more chronic diseases are being treated and the treatment plan becomes more complicated
BPC-157 BPC-157 is generally well-tolerated in animal and limited human studies
Stage 3: Brain Fog, Anxiety, & Cognitive Disruption You may think brain fog doesnt sound like a medical condition, but it is